Oct 18 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- QTRLY REVENUE OF $A92.3 MILLION, AN INCREASE OF 35% ON Q4 23
- EXPECT TO DELIVER POSITIVE OPERATING CASH FLOW FOR FY24.
- EXPECTS CASH GENERATION FROM OPERATIONS TO IMPROVE MOVING INTO SECOND HALF OF YEAR
- EXPECTS ALL THREE BUSINESS SEGMENTS TO DELIVER POSITIVE CONTRIBUTION MARGIN IN FY24
Oct 18 (Reuters) - Mayne Pharma Group Ltd (MYX) : QTRLY REVENUE...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.01 |
Change
0.020(0.40%) |
Mkt cap ! $407.8M | |||
| Open | High | Low | Value | Volume |
| $4.98 | $5.03 | $4.98 | $307.4K | 61.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 32970 | $5.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.01 | 3362 | 16 |
View Market Depth
| Last trade - 15.20pm 11/08/2025 (20 minute delay) ? |
| MYX (ASX) Chart |